Acamprosate Calcium NDC 0615-8660

NDC codes

FDA NDC Directory

Product NDC (as listed)0615-8660Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00615-8660Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0615-8660-39	00615866039	30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-8660-39)Marketed from Sep 15, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Acamprosate Calcium
Generic name (nonproprietary): acamprosate calcium
Active ingredients: Acamprosate calcium — 333 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: NCS HealthCare of KY, LLC dba Vangard Labs
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219904
Marketing start: Dec 1, 2025
Listing expires: Dec 31, 2027
Identifiers: Product ID 0615-8660_d1900128-c353-4453-bbc2-854e9043edccSPL ID d1900128-c353-4453-bbc2-854e9043edcc

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400615866039 followed by a unit qualifier and the quantity

Package 00615-8660-39. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 219904

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219904
Product	Strength	Form · route	Labeler	Product NDC
Acamprosate Calcium	Acamprosate calcium 333 mg/1	Tablet, Delayed releaseOral	Bionpharma Inc.,	69452-353